- Details
- Description
Packaging Size:
As stated on the product packaging
Strength:
2.5 mg
Composition:
Mavacamten 2.5 mg
Treatment:
Symptomatic obstructive hypertrophic cardiomyopathy (NYHA class II–III) in adults, as prescribed by a healthcare professional.
Form:
Capsule
Brand:
LuciMava
Quantity Unit:
Capsules
Manufacturer:
Lucius Pharma
LuciMava 2.5 mg (Mavacamten) is a prescription medicine used for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy. It works by reducing excessive cardiac muscle contraction, helping improve the heart’s ability to pump blood efficiently.
LuciMava 2.5 mg is intended for oral use and should be taken according to the instructions of a qualified healthcare professional. Treatment requires appropriate medical supervision and monitoring.
